Sources · 208 listed

Sources behind the answers.

Find the sources behind these pages: drug labels, agency records, studies in people, and early studies in cells or animals. Each source shows which peptide reviews use it.

Search sources

Showing 161–180 of 208 sources

Source types explained

Official records and labels include agency records and product labels. Studies in people test a substance in people. Trial plans and status show planned or ongoing studies; they may not include results. Body changes in people covers studies of how a substance acts in people. Reviews and early studies cover research reviews and studies in cells or animals.

161

Human pharmacologyPubMed · Frontiers in Human Neuroscience · 2018Checked 2026-08-30

Resting brain-scan study in 24 healthy adults

Reviews using this sourceSemax

Sources behind the answers.

Resting brain-scan study in 24 healthy adults

N-acetyl Semax amidate identity record

FDA advisory committee backs two more peptides, rejects one for compounding list

FDA substance record for Selank, Selanc, and TP-7

FDA current substance record showing the related Selank diacetate form

Selank compared with medazepam in 62 people

Selank compared with phenazepam in 60 people

Phenazepam alone compared with phenazepam plus Selank in 70 people

Selank, Semax, and placebo brain-scan study in 52 healthy people

Drugs@FDA approved-drug search

FDA Global Substance Registration System record for emideltide (DSIP)

FDA evaluation of emideltide (DSIP) and related bulk drug substances

DSIP amino-acid sequence, synthesis, and activity

Acute and delayed effects of DSIP on human sleep behavior

Synthetic DSIP and disturbed human sleep

Synthetic DSIP and sleep in people with insomnia

DSIP and 24-hour sleep-wake behavior in severe chronic insomnia

DSIP efficacy study in chronic insomnia

Double-blind DSIP study in chronic insomnia

DSIP and narcolepsy

How this list works